首页> 外文期刊>BMC Cancer >IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production
【24h】

IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production

机译:免疫功能CRP通过反应性氧物种生产在HeLa细胞中诱导细胞周期骤停和Caspase-rounds-Insumply Cell死亡

获取原文

摘要

Regulated cell death (RCD) is a mechanism by which the cell activates its own machinery to self-destruct. RCD is important for the maintenance of tissue homeostasis and its deregulation is involved in diseases such as cervical cancer. IMMUNEPOTENT CRP (I-CRP) is a dialyzable bovine leukocyte extract that contains transfer factors and acts as an immunomodulator, and can be cytotoxic to cancer cell lines and reduce tumor burden in vivo. Although I-CRP has shown to improve or modulate immune response in inflammation, infectious diseases and cancer, its widespread use has been limited by the absence of conclusive data on the molecular mechanism of its action. In this study we analyzed the mechanism by which I-CRP induces cytotoxicity in HeLa cells. We assessed cell viability, cell death, cell cycle, nuclear morphology and DNA integrity, caspase dependence and activity, mitochondrial membrane potential, and reactive oxygen species production. I-CRP diminishes cell viability in HeLa cells through a RCD pathway and induces cell cycle arrest in the G2/M phase. We show that the I-CRP induces caspase activation but cell death induction is independent of caspases, as observed by the use of a pan-caspase inhibitor, which blocked caspase activity but not cell death. Moreover, we show that I-CRP induces DNA alterations, loss of mitochondrial membrane potential, and production of reactive-oxygen species. Finally, pretreatment with N-acetyl-L-cysteine (NAC), a ROS scavenger, prevented both ROS generation and cell death induced by I-CRP. Our data indicate that I-CRP treatment induced cell cycle arrest in G2/M phase, mitochondrial damage, and ROS-mediated caspase-independent cell death in HeLa cells. This work opens the way to the elucidation of a more detailed cell death pathway that could potentially work in conjunction with caspase-dependent cell death induced by classical chemotherapies.
机译:调节细胞死亡(RCD)是细胞激活其自身机制以自毁的机制。 RCD对于维持组织稳态是重要的,其放松管制参与宫颈癌等疾病。免疫功能CRP(I-CRP)是一种可透析的牛白细胞提取物,其含有转移因子并用作免疫调节剂,并且可以是癌细胞系的细胞毒性,并降低体内肿瘤负担。虽然I-CRP已经显示出改善或调节炎症,传染病和癌症的免疫反应,但其广泛的使用受到关于其行动分子机制的确凿数据的限制。在这项研究中,我们分析了I-CRP在HeLa细胞中诱导细胞毒性的机制。我们评估了细胞活力,细胞死亡,细胞周期,核形态和DNA完整性,胱天蛋白酶依赖性和活性,线粒体膜电位和反应性氧物种生产。 I-CRP通过RCD途径降低HeLa细胞中的细胞活力,并在G2 / M相中诱导细胞周期停滞。我们表明I-CRP诱导胱天冬酶活动,但细胞死亡诱导与通过使用泛胱天蛋白酶抑制剂观察到的胱天蛋白酶,该胰蛋白酶抑制剂观察到,该胰蛋白酶抑制剂阻断了胱天蛋白酶活性但不死的细胞死亡。此外,我们表明I-CRP诱导DNA改变,线粒体膜势丧失,并产生反应性氧物种。最后,用N-乙酰基-1-半胱氨酸(NAC),ROS清除剂的预处理阻止了I-CRP诱导的ROS生成和细胞死亡。我们的数据表明,在HeLa细胞中,I-CRP治疗诱导G2 / M相,线粒体损伤和ROS介导的Caspase无关的细胞死亡中的细胞周期停滞。这项工作开辟了阐明更详细的细胞死亡途径,这些途径可能与经典化疗诱导的Caspase依赖性细胞死亡相结合。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号